DGF

1

Review clinical trials related to DGF. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

The primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom from dialysis in adult participants who are at high risk of DGF after undergoing transplant of deceased donor kidney.

Participants needed: 450
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Alexion Pharmaceuticals, Inc.Updated: Jun 18, 2026Locations: 130
Eligibility criteria

≥ 18 years of age at the time of signing the informed consent [+3]

Is to receive a kidney from a donor with category I,II,IV and V Maastricht Class... [+1]